Stay updated with breaking news from Expression Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Inherited types of anemia encompass a group of genetic disorders characterized by a deficiency in the production, structure, or function of...
The current therapeutic landscape of hemophilia A in the United States is driven by several approved therapies. The hemophilia A market is estimated to grow for the period 2019–2032. The major reason behind the hemophilia A market upsurge is the launch of the most anticipated gene therapies, which are considered as a threat to the current hemophilia A market.New York, USA, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Hemophilia A Market to Exhibit Growth at a Remarkable CAGR During the Study Period (2019-2
/PRNewswire/ -- DelveInsight's Hemophilia Market Insights report includes a comprehensive understanding of current treatment practices, hemophilia emerging...
/PRNewswire/ -- DelveInsight's 'Hemophilia Pipeline Insight – 2022' report provides comprehensive global coverage of available, marketed, and pipeline...
Hemophilia pipeline constitutes 75+ key companies continuously working towards developing 80+ Hemophilia treatment therapies, analyzes DelveInsight LAS VEGAS, Oct. 19, 2022 /PRNewswire/